US20260347310
2026-11-05
Chemistry; metallurgy
C07C217/60
The patent application introduces phenalkylamine compounds designed for medical use, particularly in treating psychiatric disorders. These compounds are formulated into pharmaceutical compositions and methods for their preparation are detailed. The application highlights the therapeutic potential of these compounds in addressing psychiatric diseases by administering effective doses to patients in need.
Psychiatric disorders such as depression and anxiety remain significant global health challenges. Current medications often fail to provide adequate relief, and when they do, the effects can be slow to manifest. There is growing interest in exploring compounds like LSD and psilocybin for their potential therapeutic benefits, despite their hallucinogenic effects and classification as Schedule I drugs. The need for therapeutic compounds that offer benefits without hallucinogenic effects is emphasized.
The disclosed compounds act as modulators of 5-HT2A receptors, offering potential treatment for psychiatric disorders such as depression, anxiety, and substance-use disorders. Additionally, they may treat headaches, inflammatory diseases, and high intraocular pressure. The compounds are designed to provide therapeutic effects while minimizing or eliminating hallucinogenic activity, thus reducing the potential for abuse.
The patent outlines several embodiments of therapeutic compounds with specific structural formulas. These include R-enantiomeric structures and compositions that may contain pharmaceutically acceptable salts. Different embodiments describe variations in molecular structure, such as the presence of specific functional groups, with details on their enantiomeric purity and potential pharmaceutical forms.
The application includes technical definitions and terms relevant to the compounds and their use. It discusses the preparation of pharmaceutically acceptable salts and carriers, ensuring compatibility with medical administration. The document also addresses the potential for these compounds to be used in a wide range of mammals, emphasizing their versatility and applicability in both human and veterinary medicine.